Loading…
Loading…
| RVMD | Revolution Medicines, Inc. | $210.02 | $44.6B |
| PTGX | Protagonist Therapeutics, Inc. | $145.72 | $9.4B |
| NUVL | Nuvalent, Inc. | $123.96 | $9.1B |
| ACLX | Arcellx, Inc. | $115.07 | $6.7B |
| KNSA | Kiniksa Pharmaceuticals International, plc | $77.91 | $5.9B |
| AKRO | Akero Therapeutics, Inc. | $54.65 | $4.5B |
| RLAY | Relay Therapeutics, Inc. | $19.04 | $4.2B |
| QURE | uniQure N.V. | $44.50 | $3.1B |
| VRDN | Viridian Therapeutics, Inc. | $22.92 | $2.6B |
| STOK | Stoke Therapeutics, Inc. | $29.81 | $1.9B |
| SNDX | Syndax Pharmaceuticals, Inc. | $20.56 | $1.8B |
| CGEM | Cullinan Therapeutics, Inc. | $22.09 | $1.4B |
| MGTX | MeiraGTx Holdings plc | $13.89 | $1.3B |
| SLDB | Solid Biosciences Inc. | $10.25 | $1.0B |
| VTYX | Ventyx Biosciences, Inc. | $14.00 | $1.0B |
| RCKT | Rocket Pharmaceuticals, Inc. | $3.86 | $421.5M |
| INZY | Inozyme Pharma, Inc. | $4.00 | $258.2M |
| RNA | Atrium Therapeutics, Inc. | $14.19 | $242.7M |
| BDTX | Black Diamond Therapeutics, Inc. | $2.12 | $121.5M |
| PLRX | Pliant Therapeutics, Inc. | $1.16 | $71.8M |